Pharmaceuticals
Company Overview of Afferent Pharmaceuticals, Inc.
Key Executives for Afferent Pharmaceuticals, Inc.
| Name | Board Relationships | Title | Age |
| Bruce G. McCarthy M.D. | No Relationships | Chief Executive Officer | -- |
| Anthony P. Ford Ph.D. | No Relationships | Co-founder and Chief Scientific Officer | -- |
| Kevin P. Starr | 56 Relationships | Chairman and Partner | 49 |
Afferent Pharmaceuticals, Inc. Board Members*
| Name | Board Relationships | Primary Company | Age |
| Kevin P. Starr | 56 Relationships | Afferent Pharmaceuticals, Inc. | 49 |
| Arthur M. Pappas | 119 Relationships | Pappas Ventures | 64 |
| Liam Ratcliffe M.D., Ph.D. | 26 Relationships | New Leaf Venture Partners | 49 |
| Jesse I. Treu Ph.D. | 78 Relationships | Domain Associates, L.L.C. | 65 |
Afferent Pharmaceuticals, Inc. Executive Committees*
| Committee Name | Chairperson | Board Relationships | Members | |
| There is no committee data available. | ||||
CEO COMPENSATION IN THIS INDUSTRY
| Industry Range | ||
| Salary | 409.0K | |
| Bonus | 477.5K | |
| Total Short Term Compensation | 561.0K | |
| Total Value of Options | 10.5M |
INDUSTRY EXECUTIVE CHANGES
Post a JobJobs
- Greenville, NC | Vidant Medical CenterPosted: May 15
- New Brunswick, NJ | Tridiagonal SolutionsPosted: Apr 24
- Field, KY | Shire PharmaceuticalsPosted: May 18
- Field, KY | Shire PharmaceuticalsPosted: May 18
Sponsored Financial Commentaries
Sponsored Links
To contact Afferent Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








